Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
NEWBORN SCREENING IN LEBANON AND THE MIDDLE EAST: REALITIES, NEEDS AND PROSPECTS FOR COLLABORATION Issam KHNEISSER Newborn Screening Manager Saint Joseph University (USJ) Beirut, Lebanon INTRODUCTION • Large economic disparities among Middle-East countries: * From low-income: Yemen, Egypt… * To oil-rich economies: Gulf countries… * With war-torn countries: Iraq, Sudan, Palestine • Affect the buying power of the state and the individual in terms of health expenditures INTRODUCTION • Large disparities in health care delivery system: * From almost totally public: Yemen, Oman… * To mixed patterns: Gulf countries, Jordan… * To mostly private: Lebanon, Palestine… • Health policies rarely based on evidence obtained from health system research. INTRODUCTION • In all ME countries, congenital disorders remain a major concern in pediatric morbidity, mostly in relation with persistent high levels of consanguinity • Various levels of mandatory newborn screening (NBS) programs in ME countries: mostly congenital hypothyroidism, sickle-cell anemia, phenylketonuria INTRODUCTION 1. Pilot from King Faysal Hospital, Ryad, KSA, to be expanded soon (Leader in TMS) 2. USJ and AUB (Lebanon) 3. Congenital hypothyroidism in Egypt 4. Piloting to restart in Kuwait 5. Piloting in Qatar to be expanded by 2009 6. PKU, Sickle cell, CH, CAH and TMS UAE 7. Piloting metabolic disorders in Yemen 8. CH and PKU screening pilot in Jordan 9. Piloting metabolic disorders in Oman 10. CH in Iran 11. Piloting Hemoglobinophathies in bahrain Introduction • Collaboration for Quality Assurance : - KSA, Lebanon and CDC NSQAP - UAE UK NEQAS • Collaboration for Quality Improvement for MS/MS: - KSA and Lebanon «www.region4genetics.com» INTRODUCTION MOST IMPORTANT OBSTACLES: • Absence of technical structures which forces specimens to be shipped out: * Yemen to KSA * Qatar to Heidelberg, Germany * Lebanon to Hamburg, Germany 2. Unavailability of funds for global screening in countries with high birth rates 3. Lack of specialized physicians and treatment facilities/capacities LEBANON • Population estimated at 4 millions with 70,000 newborn babies per year • USJ-NBS program actually covers about 20% of newborn babies. • AUB-NBS covers about 3% of deliveries which occur at the AUB Hospital • Many private hospitals have their own particular screening programs for CH and various hemoglobinopathies • About 60% of newborns do not benefit from any neonatal screening for various reasons LEBANON • Since 1996, USJ a private, community-based university chartered in 1875, has established an out-of-pocket money NBS center covering 4 diseases: • In 11 years, 130,000 babies have been screened: – – – – 85 cases of Congenital Hypothyroidism: 1/1500 720 cases of G6PD Deficiency: 1% among boys 13 cases of Phenylketnuria (1 DHPR,10 PKU, 2 HPA) 4 cases of Congenital Galactosemia (2 Classical, 2 Duarte). LEBANON • Since November 2006, an expanded screening pilot study was launched in collaboration with the Hamburg newborn screening laboratory. • Includes in-born errors of metabolism: fatty acids, amino acids, organic acids… • Abnormal results are reported within 5 days after shipment. • Assuring a confirmatory analysis and follow up. • Technical capacity transfer to Beirut will be done though expensive. • Challenge: keeping cost as low as possible for out-of-pocket clients. CONCLUSION: AVENUES FOR COLLABORATION 1. Finding the financial and political will to expand and mandate neonatal screening programs to all newborns 2. Seeking funds for equipment acquisition or leasing to buy 3. Improving in-country collaborative efforts to avoid multiplying costly equipment with no return on investment 4. Running cost-effectiveness analysis tool for decision making One good first step in Lebanon (and elsewhere): Setting up a National Advisory Committee for Neonatal Screening soon. THANK YOU